Luye Pharma Group (HKG:2186) said its offer to buy back $180 million in previously issued convertible bonds was undersubscribed, according to a Thursday filing with the Hong Kong bourse.
The firm received valid acceptances for $89.7 million of the notes, leaving $90.3 million of the 6.25% convertible bonds outstanding following the repurchase.